FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

1197141004: Product containing precisely amoxicillin 250 milligram and clavulanic acid (as clavulanate potassium) 62.5 milligram/1 each conventional release chewable tablet (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 28-Feb 2022. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
4695076018 Amoxicillin 250 mg and clavulanic acid (as clavulanate potassium) 62.5 mg chewable tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4695077010 Product containing precisely amoxicillin 250 milligram and clavulanic acid (as clavulanate potassium) 62.5 milligram/1 each conventional release chewable tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Amoxicillin 250 mg and clavulanic acid (as clavulanate potassium) 62.5 mg chewable tablet Is a Amoxicillin and clavulanic acid only product in oral dose form true Inferred relationship Some
Amoxicillin 250 mg and clavulanic acid (as clavulanate potassium) 62.5 mg chewable tablet Has manufactured dose form Chewable tablet true Inferred relationship Some
Amoxicillin 250 mg and clavulanic acid (as clavulanate potassium) 62.5 mg chewable tablet Has unit of presentation Tablet (unit of presentation) true Inferred relationship Some
Amoxicillin 250 mg and clavulanic acid (as clavulanate potassium) 62.5 mg chewable tablet Plays role Antibacterial therapeutic role (role) false Inferred relationship Some
Amoxicillin 250 mg and clavulanic acid (as clavulanate potassium) 62.5 mg chewable tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Amoxicillin (substance) true Inferred relationship Some 1
Amoxicillin 250 mg and clavulanic acid (as clavulanate potassium) 62.5 mg chewable tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Amoxicillin (substance) true Inferred relationship Some 1
Amoxicillin 250 mg and clavulanic acid (as clavulanate potassium) 62.5 mg chewable tablet This attribute specifies the numerator unit for the presentation strength of a product. mg true Inferred relationship Some 1
Amoxicillin 250 mg and clavulanic acid (as clavulanate potassium) 62.5 mg chewable tablet This attribute specifies the denominator unit for the presentation strength of a product. Tablet (unit of presentation) true Inferred relationship Some 1
Amoxicillin 250 mg and clavulanic acid (as clavulanate potassium) 62.5 mg chewable tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Clavulanate potassium (substance) true Inferred relationship Some 2
Amoxicillin 250 mg and clavulanic acid (as clavulanate potassium) 62.5 mg chewable tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Clavulanic acid (substance) true Inferred relationship Some 2
Amoxicillin 250 mg and clavulanic acid (as clavulanate potassium) 62.5 mg chewable tablet This attribute specifies the numerator unit for the presentation strength of a product. mg true Inferred relationship Some 2
Amoxicillin 250 mg and clavulanic acid (as clavulanate potassium) 62.5 mg chewable tablet This attribute specifies the denominator unit for the presentation strength of a product. Tablet (unit of presentation) true Inferred relationship Some 2
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start